T14 Making an Impact: Innovation in the Production of Medical Radioisotopes

Sponsored by the Office of Nuclear Reactor Regulation

By adapting its approach to non-power reactor regulation, the NRC staff applies a scaled approach to the licensing and oversight of first-of-a-kind medical radioisotope facilities intended to support the establishment of a reliable supply of molybdenum-99.  This session will highlight the significance of molybdenum-99 production; challenges to establishing a reliable supply of medical radioisotopes; the importance of technology and regulatory innovation; and the impact of medical radioisotope production on the future of the nuclear industry.  Panelists will provide insights on right-sizing licensing reviews and inspections; adapting regulatory tools for new technologies; and effective engagement practices to facilitate regulatory decisions of non-power production and utilization facilities (NPUFs).  NRC staff and industry will discuss key challenges, successes, and lessons learned in the areas of pre-application coordination; technology development; licensing reviews; and inspection of new NPUFs.  This session will demonstrate an ability of the NRC staff to effectively regulate novel technologies by evolving its processes based on the minimal risks posed by new NPUF facilities and ongoing coordination with prospective applicants; current applicants; and licensees.

• Brian Smith, Deputy Director, Division of Advanced Reactors and Non-Power Production and Utilization Facilities, NRR tel: 301-415-7364, e-mail: Brian.Smith@nrc.gov

   

• Introductory Remarks
  Brian Smith, Deputy Director, Division of Advanced Reactors and Non-Power Production and Utilization Facilities, NRR/NRC
• Roy Brown, Vice President, Government Affairs & Strategic Alliances, Curium Pharma
• Joanie Dix, Deputy Director, Office of Conversion, National Nuclear Security Administration, U.S. Department of Energy
• James Harvey, SVP & Chief Science Officer, NorthStar Medical Technologies, LLC
• Greg Piefer, Chief Executive Officer and Founder, SHINE Medical Technologies, LLC
• John Witkowski, President, UPPI, LLC

• Steve Lynch, Project Manager, Non-Power Production and Utilization Facilities Licensing Branch, Division of Advanced Reactors and Non-Power Production and Utilization Facilities, NRR/NRC tel: 301-415-1524, e-mail: Steve.Lynch@nrc.gov